IXC 10.5% 6.0¢ invex therapeutics ltd

The issue with IXC's technology is the market size. NYR's tech...

  1. 387 Posts.
    lightbulb Created with Sketch. 47
    The issue with IXC's technology is the market size. NYR's tech addresses brain injury after stroke (which has a much larger market than TBI) and can extend very easily to other indications. But I agree that IXC"s share price can turn around very quickly after a successful Phase 2 in TBI.
 
watchlist Created with Sketch. Add IXC (ASX) to my watchlist
(20min delay)
Last
6.0¢
Change
-0.007(10.5%)
Mkt cap ! $4.509M
Open High Low Value Volume
6.0¢ 6.0¢ 6.0¢ $3.264K 54.4K

Buyers (Bids)

No. Vol. Price($)
1 600 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
7.0¢ 20000 1
View Market Depth
Last trade - 16.10pm 28/06/2024 (20 minute delay) ?
IXC (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.